Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Zhejiang UniversityActive in the last 2 years

Dongkai Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0705-9796; OpenAlex author ID A5055728817. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 2 papers · 2025: 1 paper

Papers 10

  1. Integration of bulk and single-cell transcriptomic data reveals a novel signature related to liver metastasis and basement membrane in pancreatic cancer. Co-author DOI 10.3389/fimmu.2025.1671956↗
  2. Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis. Last author DOI 10.1186/s40001-024-01823-6↗
  3. Corrigendum: The role of microtubules in pancreatic cancer: therapeutic progress. Co-author DOI 10.3389/fonc.2024.1414456↗
  4. USPs in Pancreatic Ductal Adenocarcinoma: A Comprehensive Bioinformatic Analysis of Expression, Prognostic Significance, and Immune Infiltration. First author DOI 10.1155/2022/6109052↗
  5. The Role of Microtubules in Pancreatic Cancer: Therapeutic Progress. Co-author DOI 10.3389/fonc.2021.640863↗
  6. Overexpression of α3, β3 and γ2 chains of laminin-332 is associated with poor prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ol.2018.8678↗
  7. miR‑448 targets Rab2B and is pivotal in the suppression of pancreatic cancer. Co-author DOI 10.3892/or.2018.6562↗
  8. HINT2 triggers mitochondrial Ca2+ influx by regulating the mitochondrial Ca2+ uniporter (MCU) complex and enhances gemcitabine apoptotic effect in pancreatic c… Co-author DOI 10.1016/j.canlet.2017.09.020↗
  9. Therapeutic efficacy and safety of S-1-based combination therapy compare with S-1 monotherapy following gemcitabine failure in pancreatic cancer: a meta-analys… Co-author DOI 10.1038/srep36944↗
  10. Overexpression of β3 Chains of Laminin-332 is Associated With Clinicopathologic Features and Decreased Survival in Patients With Pancreatic Adenocarcinoma. Co-author DOI 10.1097/pai.0000000000000115↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Weilin Wang · 7 shared papers, 2015–2024 · strength 0.82
  2. Yizhi Wang · 2 shared papers, 2024–2025 · strength 0.61
  3. Mugahed Abdullah Hasan Albahde · 2 shared papers, 2021–2024 · strength 0.37
  4. Hao Xu · 2 shared papers, 2021–2024 · strength 0.37
  5. Yizhi Wang · 1 shared paper, 2022 · strength 0.19
  6. Yuan Ding · 1 shared paper, 2022 · strength 0.19
  7. Shusen Zheng · 3 shared papers, 2015–2017 · strength 0.16
  8. Jun Chen · 2 shared papers, 2015–2018 · strength 0.14
  9. Jing Jin · 1 shared paper, 2018 · strength 0.11
  10. Shian Yu · 1 shared paper, 2018 · strength 0.09
  11. Hangping Yao · 1 shared paper, 2017 · strength 0.06
  12. Linghui Chen · 1 shared paper, 2017 · strength 0.06
  13. Wei Song · 1 shared paper, 2017 · strength 0.06
  14. Sinan Lu · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.